Tag: Lotus Pharmaceutical

Róbert Wessman-led Aztiq and Innobic join forces in $475m acquisition of Lotus Pharmaceutical and Adalvo

by  • 

Aztiq, a healthcare investor led by Alvogen Founder and Chairman Róbert Wessman, and Innobic (Asia) Company Limited, a life sciences subsidiary of Thailand industrial group PTT, has announced the signing of a definitive agreement to acquire a 100% stake in Alvogen Emerging Market Holdings Limited from its existing shareholders for $475 million. Aztiq’s founder and…

read more..

PTT Invests in Lotus Pharmaceutical’s Strategic Partnership in South East Asia

by  • 

Lotus Pharmaceutical Co., Ltd, an Alvogen company, has announced the issuance of new shares through private placement to be acquired by Innobic (Asia). The move is aimed at strengthening the company’s market access in the ASEAN region. Innobic (Asia) is a wholly owned subsidiary of PTT Public Company Limited, a publicly listed conglomerate in Thailand.…

read more..